EditorialAmy Rothberg, a professor of medicine at the University of Michigan and the medical director of Rewind, a company that counsels diabetic patients, in Ann Arbor, Mich., June 7, 2023. (Cydni Elledge/The New York Times)
EditorialAmy Rothberg, a professor of medicine at the University of Michigan and the medical director of Rewind, a company that counsels diabetic patients, in Ann Arbor, Mich., June 7, 2023. (Cydni Elledge/The New York Times)
EditorialAmy Rothberg, a professor of medicine at the University of Michigan and the medical director of Rewind, a company that counsels diabetic patients, in Ann Arbor, Mich., June 7, 2023. (Cydni Elledge/The New York Times)
EditorialAmy Rothberg, a professor of medicine at the University of Michigan and the medical director of Rewind, a company that counsels diabetic patients, in Ann Arbor, Mich., June 7, 2023. (Cydni Elledge/The New York Times)
EditorialAmy Rothberg, a professor of medicine at the University of Michigan and the medical director of Rewind, a company that counsels diabetic patients, in Ann Arbor, Mich., June 7, 2023. (Cydni Elledge/The New York Times)
EditorialAmy Rothberg, a professor of medicine at the University of Michigan and the medical director of Rewind, a company that counsels diabetic patients, in Ann Arbor, Mich., June 7, 2023. (Cydni Elledge/The New York Times)